Two sources of pain (text image)

  One source of relief (text image)

NUCYNTA® ER (tapentadol) is the first and only FDA-approved long-acting opioid designed to control both nociceptive pain and the neuropathic pain associated with diabetic peripheral neuropathy (DPN).
Not an actual patient.

THE COMPLEXITY OF
CHRONIC PAIN



Review the two main types of pain physiology: nociceptive and neuropathic pain.

LEARN MORE

CO-PAY SAVINGS
FOR ELIGIBLE PATIENTS



NUCYNTA ER offers confidence of access and low out‑of‑pocket costs for your patients.

LEARN MORE